Literature DB >> 15896780

Differential interactions of the homeodomain-interacting protein kinase 2 (HIPK2) by phosphorylation-dependent sumoylation.

Ki Sa Sung1, Yoon Young Go, Jin-Hyun Ahn, Young Ho Kim, Yongsok Kim, Cheol Yong Choi.   

Abstract

Homeodomain-interacting protein kinase 2 (HIPK2) interacts with and phosphorylates various transcription factors that are critical regulators of cell fate decisions and apoptosis during development. Here we show that lysine 25 of HIPK2 is the major sumoylation site, both in vitro and in vivo, and that the sumoylation of this site occurs in a phosphorylation-dependent manner. This became clear with the finding that kinase-dead HIPK2 (K221R) could not be efficiently sumoylated in vitro. The sumoylation of HIPK2 resulted in the disruption of its interaction with a Groucho corepressor. Consequently, sumoylation inhibited the regulatory activity of HIPK2 on the Groucho-mediated repression of transcription, whereas not on p53-mediated transactivation. These results suggest that phosphorylation-dependent sumoylation enables HIPK2 to drive different target gene transcription by means of differential interactions with its binding partners.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15896780     DOI: 10.1016/j.febslet.2005.04.053

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

Review 1.  Emerging roles of the SUMO pathway in development.

Authors:  Hilda Lomelí; Martha Vázquez
Journal:  Cell Mol Life Sci       Date:  2011-09-04       Impact factor: 9.261

2.  Pellino-1, an adaptor protein of interleukin-1 receptor/toll-like receptor signaling, is sumoylated by Ubc9.

Authors:  Jun Hwan Kim; Ki Sa Sung; Su Myung Jung; Youn Sook Lee; Jae Young Kwon; Cheol Yong Choi; Seok Hee Park
Journal:  Mol Cells       Date:  2010-11-25       Impact factor: 5.034

3.  miR-770-5p modulates resistance to methotrexate in human colorectal adenocarcinoma cells by downregulating HIPK1.

Authors:  Dawei Zhang; Ying Li; Peilong Sun
Journal:  Exp Ther Med       Date:  2019-11-19       Impact factor: 2.447

4.  The crystal structure of the protein kinase HIPK2 reveals a unique architecture of its CMGC-insert region.

Authors:  Christopher Agnew; Lijun Liu; Shu Liu; Wei Xu; Liang You; Wayland Yeung; Natarajan Kannan; David Jablons; Natalia Jura
Journal:  J Biol Chem       Date:  2019-07-24       Impact factor: 5.157

5.  Overlapping roles for homeodomain-interacting protein kinases hipk1 and hipk2 in the mediation of cell growth in response to morphogenetic and genotoxic signals.

Authors:  Kyoichi Isono; Kazumi Nemoto; Yuanyuan Li; Yuki Takada; Rie Suzuki; Motoya Katsuki; Akira Nakagawara; Haruhiko Koseki
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

6.  Different functions of HIPK2 and CtBP2 in traumatic brain injury.

Authors:  Feihui Zou; Jian Xu; Hongran Fu; Jianhua Cao; Hui Mao; Mingjie Gong; Gang Cui; Yang Zhang; Wei Shi; Jian Chen
Journal:  J Mol Neurosci       Date:  2012-10-18       Impact factor: 3.444

7.  HIPK1 drives p53 activation to limit colorectal cancer cell growth.

Authors:  Christophe Rey; Isabelle Soubeyran; Isabelle Mahouche; Stephane Pedeboscq; Alban Bessede; François Ichas; Francesca De Giorgi; Lydia Lartigue
Journal:  Cell Cycle       Date:  2013-05-15       Impact factor: 4.534

8.  Function of the C. elegans T-box factor TBX-2 depends on interaction with the UNC-37/Groucho corepressor.

Authors:  Paul Huber; Tanya Crum; Peter G Okkema
Journal:  Dev Biol       Date:  2016-06-02       Impact factor: 3.582

9.  The SxxSS motif of T-cell factor-4 isoforms modulates Wnt/β-catenin signal activation in hepatocellular carcinoma cells.

Authors:  Yoshito Tomimaru; Hironori Koga; Tai Ho Shin; Chelsea Q Xu; Jack R Wands; Miran Kim
Journal:  Cancer Lett       Date:  2013-04-02       Impact factor: 8.679

10.  Shared and Tissue-Specific Expression Signatures between Bone Marrow from Primary Myelofibrosis and Essential Thrombocythemia.

Authors:  Genta Ishikawa; Naoto Fujiwara; Hadassa Hirschfield; Lilian Varricchio; Yujin Hoshida; Giovanni Barosi; Vittorio Rosti; Maria Padilla; Maria Mazzarini; Scott L Friedman; Ronald Hoffman; Anna Rita Migliaccio
Journal:  Exp Hematol       Date:  2019-11-01       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.